Charles H. Sherwood, President, CEO, Director at Anika Therapeutics, Inc. (ANIK), sold 22,437 shares at $50.00 ($1.1M) on 2017-07-03, disclosed to the SEC on 2017-07-06.
Open-market sale of $1.1M ANIK by President, CEO, Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.00 | 5,965 | $298K | 26.6% |
| 2 | $50.06 | 8,236 | $412K | 36.7% |
| 3 | $50.06 | 8,236 | $412K | 36.7% |
| Total | $50.04 avg | 22,437 | $1.1M | 100% |
| Filing → |
| ANIK | SELL | 2017-10-18 | $395K | — | Filing → |
| ANIK | SELL | 2017-10-16 | $742K | — | Filing → |
| ANIK | SELL | 2017-07-31 | $6.5M | — | Filing → |